Related Experiment Video
Updated: Aug 19, 2025

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Metoprolol Improves Left Ventricular Longitudinal Strain at Rest and during Exercise in Obstructive Hypertrophic
Anne M Dybro1, Torsten B Rasmussen1, Roni R Nielsen1
1Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Insights
Beta-blocker treatment with metoprolol improved left ventricular global longitudinal strain (GLS) during exercise in patients with obstructive hypertrophic cardiomyopathy (HCM). This indicates a beneficial effect on systolic function, despite resting impairments.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Pharmacology
Background:
- Obstructive hypertrophic cardiomyopathy (HCM) can cause exertional heart failure symptoms.
- Left ventricular (LV) ejection fraction may not fully capture systolic dysfunction in HCM.
- Longitudinal strain (LS) is a sensitive marker for LV systolic dysfunction in HCM.
Purpose of the Study:
- To characterize LV segmental and global longitudinal strain (GLS) at rest and during exercise in obstructive HCM.
- To evaluate the effect of beta-blocker treatment on LV systolic performance in these patients.
Main Methods:
- A double-blind, placebo-controlled, randomized crossover trial involving 29 patients with obstructive HCM.
- Patients received metoprolol or placebo for two 2-week periods.
- Echocardiography with speckle-tracking-derived LS assessed at rest and peak exercise.
Main Results:
- Resting LV segmental LS showed an apical-basal difference, with severely abnormal basal segments.
- Metoprolol treatment improved LS in apical and mid segments compared to placebo.
- During peak exercise, metoprolol was associated with improved LV GLS.
Conclusions:
- LV GLS is impaired at rest and during exercise in obstructive HCM.
- Metoprolol treatment demonstrated a beneficial effect on LV systolic function during exercise.
- Beta-blockers may improve exercise capacity and symptoms in obstructive HCM patients.
Background:
Patients with obstructive hypertrophic cardiomyopathy (HCM) often experience symptoms of heart failure upon exertion despite having normal left ventricular (LV) ejection fractions. Longitudinal strain (LS) may be a more sensitive marker of systolic dysfunction in patients with LV hypertrophy. The aims of this study were to characterize LV segmental LS and global LS (GLS) at rest and during exercise and to assess if first-line treatment with β-blockers improves LV systolic performance.
Methods:
Twenty-nine patients with obstructive HCM and New York Heart Association functional class ≥ II symptoms were enrolled in a double-blind, placebo-controlled, randomized crossover trial. Patients received metoprolol 150 mg or placebo for two consecutive 2-week periods in random order. Echocardiographic assessment with speckle-tracking-derived LS was performed at rest and during peak exercise at the end of each treatment period.
Results:
During placebo treatment, resting values of segmental LS showed an apical-basal difference of -10.3% (95% CI, -12.7% to -7.8%; P < .0001), with a severely abnormal value of the basal segment of -9.3 ± 4.2%. Treatment with metoprolol was associated with more negative LS values of the apical segment (-2.8%; 95% CI, -4.2% to -1.3%; P < .001) and the mid segment (-1.1%; 95% CI, -2.0% to -0.3%; P = .007). During peak exercise there was a deterioration in LV GLS, but treatment with metoprolol was associated with more negative peak exercise LV GLS (-1.3 %; 95% CI, -2.6% to -0.1%; P = .03).
Conclusions:
Systolic performance assessed by LV GLS showed impaired values at rest and during exercise, with severely depressed values of the basal and mid segments. Treatment with metoprolol improved LV GLS upon exercise, indicating a beneficial effect of β-blocker treatment on LV systolic function.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: β-Blockers
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis I: Introduction

